Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioLineRx Ltd. BLRX

Full chart Compare
Set alert

Price alert · BLRX

All alert types
1.89 USD -0.02 (-1.31%)

Nov 4, 2026, 10:38 AM EST

1.81 Day range 1.89
1.81 52-week range 3.95
YTD
-31.95%
1 year
-42.88%

Financial health

Altman Z-Score

-17.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 4

Valuation

P/E -9.6×
FY 2016: -3.3×FY 2017: -4.0×FY 2018: -2.1×FY 2019: -0.8×FY 2020: -1.4×FY 2021: -3.3×FY 2022: -1.2×FY 2023: -1.7×FY 2024: -1.9×FY 2025: -9.6×
FY 2016 5y median -1.9× FY 2025
P/S 9.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 21.0×FY 2024: 0.6×FY 2025: 9.6×
FY 2016 5y median 0.6× FY 2025
P/B 0.6×
FY 2016: 1.5×FY 2017: 1.9×FY 2018: 1.1×FY 2019: 0.7×FY 2020: 1.9×FY 2021: 1.3×FY 2022: 0.6×FY 2023: 7.6×FY 2024: 1.3×FY 2025: 0.6×
FY 2016 5y median 1.3× FY 2025
P/FCF -1.4×
FY 2016: -3.5×FY 2017: -4.0×FY 2018: -1.4×FY 2019: -1.0×FY 2020: -1.8×FY 2021: -3.8×FY 2022: -1.1×FY 2023: -4.4×FY 2024: -0.4×FY 2025: -1.4×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -81.3×
FY 2016: -3.1×FY 2017: -3.8×FY 2018: -2.4×FY 2019: -1.2×FY 2020: -1.2×FY 2021: -3.2×FY 2022: -1.5×FY 2023: -1.9×FY 2024: 5.5×FY 2025: -81.3×
FY 2016 5y median -1.9× FY 2025
EV/Sales 15.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 22.5×FY 2024: 0.7×FY 2025: 15.4×
FY 2016 5y median 0.7× FY 2025
FCF Yield -71.7%
FY 2016: -28.2%FY 2017: -25.3%FY 2018: -72.5%FY 2019: -103.5%FY 2020: -54.6%FY 2021: -26.3%FY 2022: -87.2%FY 2023: -22.7%FY 2024: -257.0%FY 2025: -71.7%
FY 2016 5y median -71.7% FY 2025

Profitability

Gross Margin 36.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 23.1%FY 2024: 68.0%FY 2025: 36.2%
FY 2016 5y median 23.1% FY 2025
Operating Margin -871.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1035.3%FY 2024: -70.5%FY 2025: -871.8%
FY 2016 5y median -70.5% FY 2025
Net Margin -99.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1262.8%FY 2024: -31.9%FY 2025: -99.6%
FY 2016 5y median -31.9% FY 2025
ROE -6.5%
FY 2016: -45.2%FY 2017: -46.1%FY 2018: -55.6%FY 2019: -76.2%FY 2020: -136.3%FY 2021: -39.7%FY 2022: -49.1%FY 2023: -458.4%FY 2024: -68.5%FY 2025: -6.5%
FY 2016 5y median -49.1% FY 2025
ROIC -31.0%
FY 2016: -46.7%FY 2017: -46.5%FY 2018: -50.8%FY 2019: -63.2%FY 2020: -57.4%FY 2021: -33.2%FY 2022: -43.1%FY 2023: -200.3%FY 2024: -71.6%FY 2025: -31.0%
FY 2016 5y median -43.1% FY 2025
ROA -2.9%
FY 2016: -40.7%FY 2017: -39.9%FY 2018: -40.8%FY 2019: -47.5%FY 2020: -63.5%FY 2021: -33.2%FY 2022: -32.7%FY 2023: -94.8%FY 2024: -23.7%FY 2025: -2.9%
FY 2016 5y median -32.7% FY 2025

Growth (YoY)

Revenue -95.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 502.9%FY 2025: -95.9%
FY 2016 FY 2025
Operating Income 49.2%
FY 2016: -2.0%FY 2017: -52.8%FY 2018: -1.4%FY 2019: -9.8%FY 2020: 18.4%FY 2021: -8.1%FY 2022: -17.7%FY 2023: -70.4%FY 2024: 58.9%FY 2025: 49.2%
FY 2016 FY 2025
EPS (diluted) 93.7%
FY 2016: 0.0%FY 2017: 3.6%FY 2018: 22.2%FY 2019: 14.3%FY 2020: 33.3%FY 2021: 66.0%FY 2022: 21.1%FY 2023: -95.3%FY 2024: 87.8%FY 2025: 93.7%
FY 2016 FY 2025
Free Cash Flow 81.4%
FY 2016: 13.7%FY 2017: -70.1%FY 2018: -38.8%FY 2019: 33.9%FY 2020: -2.1%FY 2021: -2.0%FY 2022: -12.2%FY 2023: 13.7%FY 2024: -91.8%FY 2025: 81.4%
FY 2016 FY 2025

Financial Health

Current Ratio 2.0×
FY 2016: 9.9×FY 2017: 7.5×FY 2018: 4.7×FY 2019: 2.4×FY 2020: 2.2×FY 2021: 5.9×FY 2022: 4.9×FY 2023: 1.1×FY 2024: 1.8×FY 2025: 2.0×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 1.8×
FY 2016: 9.9×FY 2017: 7.5×FY 2018: 4.7×FY 2019: 2.3×FY 2020: 2.2×FY 2021: 5.9×FY 2022: 4.9×FY 2023: 1.1×FY 2024: 1.6×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 0.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -30.7×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: -0.2×FY 2019: -0.2×FY 2020: 0.3×FY 2021: 0.3×FY 2022: -0.1×FY 2023: -0.1×FY 2024: 1.2×FY 2025: -30.7×
FY 2016 5y median -0.1× FY 2025
Interest Coverage -8.0×
FY 2016: -1180×FY 2017: -1202×FY 2018: -1219×FY 2019: -15.4×FY 2020: -15.6×FY 2021: -25.2×FY 2022: -13.5×FY 2023: -22.9×FY 2024: -2.2×FY 2025: -8.0×
FY 2016 5y median -13.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31